A detailed history of Continental Investors Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Continental Investors Services, Inc. holds 2,203 shares of NVO stock, worth $227,878. This represents 0.57% of its overall portfolio holdings.

Number of Shares
2,203
Previous 2,243 1.78%
Holding current value
$227,878
Previous $320,000 18.13%
% of portfolio
0.57%
Previous 0.73%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$119.07 - $145.42 $4,762 - $5,816
-40 Reduced 1.78%
2,203 $262,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $9,694 - $11,605
79 Added 3.65%
2,243 $320,000
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $220,966 - $294,130
2,164 New
2,164 $277,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $233,034 - $257,939
1,494 New
1,494 $241,000
Q3 2022

Nov 22, 2022

BUY
$95.28 - $116.93 $1.21 Million - $1.49 Million
12,736 New
12,736 $1.36 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Continental Investors Services, Inc. Portfolio

Follow Continental Investors Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Investors Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Continental Investors Services, Inc. with notifications on news.